Radiotherapy Clinical Trial
Official title:
A Study Utilizing 3D Printing in Patients Undergoing External Beam Radiation Therapy
Some radiation therapy treatment plans require the use of boluses. Boluses are placed directly on the skin overlying the area to be treated. The radiation beam interacts with the bolus before entering the body and ensures that the correct radiation dose reaches your tumor. The purpose of this study is to determine whether the shortcomings of conventional bolus preparation can be overcome by using a 3D printer. CT scans of the body can be used to create 3D models for boluses. The 3D models can then be printed into plastic boluses using a 3D printer. Preliminary studies have shown that 3D printed boluses conform to body contours better and allow for more precise control over radiation dose. In this study, both a conventional and 3D printed bolus will be made. The Investigators will then simulate treatment with both boluses to determine which bolus will result in more optimal treatment for the participant. The superior bolus will be used in the participant's treatment.
In radiation therapy, high-energy radiation beams treat tumors by damaging cancer cells.
Treatment plans are designed with the goal of limiting exposure to adjacent healthy tissues.
Commonly used radiation beams demonstrate the "skin-sparing effect" which means that the
radiation dose builds up after the beam enters the skin and thus the maximum dose is reached
at some depth beneath the skin. For many tumors, this spares the skin from unnecessary
exposure while ensuring cancer cells beneath the skin receive the maximum dose. For cancers
that lie at or just below the skin surface, however, it is desirable for the maximum dose be
present at the skin surface. In such cases, a bolus (material with properties similar to
tissue) is used to mimic tissue and is placed above the skin. Dose build up occurs within the
bolus, thus allowing the maximum dose to be reached at the skin surface. Aside from the
treatment of superficial tumors, boluses have recently been used for modulated electron
radiation therapy (MERT). For MERT, the bolus thickness is varied so that the dose at a
specific depth can be varied at different locations within the tissue. With this technique,
the bolus is customized for a patient's specific anatomy and thus radiation exposure to
healthy tissue is minimized.
Boluses are typically made from moldable materials such as paraffin wax or superflab.
Conventional bolus preparation has its disadvantages; the patient is required to be present,
it can be time intensive and it is dependent on the skill of the fabricator. Furthermore, the
degree of conformity to the patient's skin is limited and, as a result, there can be
significant air gaps between the bolus and the patient's skin. Such air gaps have been shown
to create significant reduction in the surface dose.
The goal of the present study is to improve the current process of bolus preparation by
creating customized boluses with 3D printing. Customized boluses can be designed in Varian
eclipse software and then imported into 3D modeling software such as 3D Slicer. The 3D model
can then be converted into STL (Stereolithography) format which can be interpreted by the 3D
printer software. Several preliminary studies have reported success in creating such boluses.
One study reported good fit without air gaps (Kim) in their 3D printed bolus. Additionally,
several studies modeled tissue dose distributions for 3D printed boluses and found results
were similar to those obtained for conventional boluses.
For the current study, the Investigators will enroll participants who require boluses as part
of their treatment plan. Both a conventional and 3D bolus will be fabricated for each
participant. Computer simulation of dose distributions will be used to compare dosimetric
parameters. Additionally, air gaps for both boluses will be measured. For each participant,
the bolus that results in a more optimized dose distribution will be used for the
participant's actual treatment. Conducting the study will necessitate each enrolled
participant to undergo an additional CT scan to simulate treatment with the 3D printed bolus.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT03212742 -
Phase I/IIa Study of Concomitant Radiotherapy With Olaparib and Temozolomide in Unresectable High Grade Gliomas Patients
|
Phase 1/Phase 2 | |
Recruiting |
NCT06190782 -
Local Therapy for Oligometastatic ESCC Patients Treated With PD-1 Inhibitor
|
Phase 3 | |
Recruiting |
NCT06120127 -
Postoperative Chemotherapy With/Without Radiotherapy and Immunotherapy for Colorectal Liver Metastases With High Risk of Locally Recurrence
|
Phase 2 | |
Recruiting |
NCT05176002 -
Camrelizumab in Combination With Radiotherapy for Neoadjuvant Esophageal Carcinoma.
|
Phase 1/Phase 2 | |
Not yet recruiting |
NCT05909137 -
Omitting Clinical Target Volume in Radical Treatment of Unresectable Stage III Non-small Cell Lung Cancer
|
||
Recruiting |
NCT02661152 -
DAHANCA 30: A Randomized Non-inferiority Trial of Hypoxia-profile Guided Hypoxic Modification of Radiotherapy of HNSCC.
|
Phase 3 | |
Withdrawn |
NCT02542137 -
Abscopal Effect for Metastatic Small Cell Lung Cancer
|
Phase 2 | |
Completed |
NCT01212731 -
Skull Base and Low Grade Glioma Neurocognitive Magnetic Resonance Imaging (MRI) Study
|
||
Completed |
NCT01168479 -
FLAME: Investigate the Benefit of a Focal Lesion Ablative Microboost in Prostate Cancer
|
Phase 3 | |
Recruiting |
NCT03658343 -
T2* MRI Analysis for Sarcoma
|
N/A | |
Completed |
NCT03280719 -
Whole Breast + Lymph Node Irradiation: Prone Compared to Supine Position in 15 or 5 Fractions
|
N/A | |
Recruiting |
NCT05515796 -
Multi-omics Sequencing in Neoadjuvant Immunotherapy of Gastrointestinal Tumors
|
Phase 2 | |
Recruiting |
NCT05514327 -
A Study of Ultra-fraction Radiotherapy Bridging CART in R/R DLBCL
|
N/A | |
Recruiting |
NCT04453826 -
Concurrent and Adjuvant PD1 Treatment Combined With Chemo-radiotherapy for High-risk Nasopharyngeal Carcinoma
|
Phase 3 | |
Recruiting |
NCT03370926 -
FET-PET and Multiparametric MRI for High-grade Glioma Patients Undergoing Radiotherapy
|
N/A | |
Active, not recruiting |
NCT03870919 -
Locoregional Treatment and Palbociclib in de Novo, Treatment Naive, Stage IV ER+, HER2- Breast Cancer Patients
|
N/A | |
Active, not recruiting |
NCT02428049 -
Radiation Pneumonitis After SBRT for NSCLC
|
||
Recruiting |
NCT04923620 -
Neoadjuvant Cetuximab + Chemotherapy Combined With Short-course Radiotherapy
|
||
Active, not recruiting |
NCT05371795 -
Comparison on Radiotherapy Permanent Skin Marking With Lancets and an Electric Marking Device
|
N/A | |
Recruiting |
NCT03210428 -
Quantitative MR Imaging in Locally Advanced Cervical Cancer
|